Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-07

Clinical Trial Update: Gluten Free Oat (Cultivar Saul) in Celiac Disease in Remission [NA]

View source ↗

Summary

Clinical trial evaluating gluten-free oat cultivar Saul in people with celiac disease in remission has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gluten Free Oat (Cultivar Saul)

Snippet

Sponsor: Faculty Hospital Kralovske Vinohrady | Conditions: Celiac Disease | NA | Status: COMPLETED